Introduction
Acute respiratory tract infections (ARIs) are a leading cause of morbidity and mortality in children worldwide [1] accounting for about 30% of all childhood deaths in the developing world. [2] Viruses account for 50-90% of acute lower respiratory tract infections (ALRIs) in young children [3] with respiratory syncytial virus (RSV), parainfl uenza viruses (PIVs), infl uenza viruses A and B and human metapneumoviruses (hMPV) being the most commonly identifi ed. [4] [5] [6] ARIs are classifi ed as upper respiratory tract infections (URIs) or lower respiratory tract infections (LRIs). ARIs are the most common causes of both illness and mortality in children under fi ve, who average middle ear, [12] and aspiration of infected secretions and cells can result in LRIs. Viral infection is assumed to precede bacterial infections and may generate the environment for bacterial super-infections. [13, 14] There is also evidence that viral infections make the lower respiratory tract more susceptible for fungal infections. [15] These fi ndings indicate the need to develop new point of care tools for the diagnosis of viral infections and the differentiation from bacterial infections or the diagnosis of viral/bacterial co-infections. The argument that viral infections are diffi cult to treat still applies for most viruses; however, there are newly developed drugs, especially monoclonal antibodies that are virus specifi c and can be used to treat or even prevent viral infections. [16] Haffkine Institute is a sentinel surveillance centre under the National Center for Disease Control (NCDC) for the detection of infl uenza viruses among the population in Mumbai. The aim of the study was to investigate other viral and bacterial infections in patients with ARIs, which generally go undetermined.
Materials and Methods
A total of 200 nasal swabs/throat swabs were collected from July 2011 to July 2012, which comprised of 114 males and 86 females from outpatient department (OPD) and inpatient department (IPD) from hospitals like B. J. Wadia Hospital for Children, L. H. Hiranandani Hospital, King Edward Memorial Hospital, Mumbai. Written informed consent was obtained from the patients or their parents/ guardians. The study was approved by the Ethical Committee of the hospitals and Institutional Ethics Committee of Haffkine Institute.
Patients presenting with ARI having the following case defi nition were included in the study: [17] Infl uenza-like Illness (ILI): • Inclusion Criteria: A person with sudden onset of fever >38°C and cough or sore throat • Exclusion Criteria: Absence of any other clinical diagnosis. Acute Respiratory Infection: • Inclusion Criteria: Cough, sore throat, shortness of breath; coryza, and a clinical judgment that illness is due to an infection.
The ILI case defi nition is generally intended for use in outpatient treatment centres and the ARI defi nitions are for inpatient hospital settings. The ARI defi nition aims to capture both the infl uenza-related pneumonias and infl uenza-related exacerbations of chronic illnesses such as asthma or heart disease.
Clinical samples were collected in viral transport medium (VTM), in a triple layer packing, in a styrofoam box containing ice packs and transported to the laboratory.
The samples were divided in three aliquots and stored in -80°C till further processing.
Viral RNA extraction
The viral RNA was extracted from clinical samples using the spin column based QIAmp Viral RNA Mini Kit (Qiagen GmbH, Hielden, Germany) as per manufacturer's instructions.
Bacterial DNA extraction
The total genomic DNA was extracted from clinical samples using spin column based HiPura TM 96 Bacterial Genomic DNA Purifi cation Kit (HiMedia, India) as per the manufacturer's instructions.
Amplifi cation of viral genome
Primer and Probes for pandemic infl uenza A H1N1, [13] seasonal infl uenza A [13] and infl uenza type B [15] were provided by NCDC, New Delhi, India, under Integrated Disease Surveillance Programme.
Primers
for hMPV, [18] RSV, [19] Streptococcus pneumoniae, Haemophilus infl uenzae, [20] Staphylococcus aureus [21] and Klebsiella pneumoniae [22] were synthesised as illustrated in Table 1 .
The Real time reverse transcriptase polymerase chain reaction (rRT-PCR) for pandemic infl uenza A H1N1, seasonal infl uenza A and infl uenza Type B was performed as described in an earlier protocol [23] on a Step One real time PCR Instrument (ABI) with an rRT-PCR containing 2× PCR master mix and Superscript TM III RT/Platinum Taqman Mix (Enzyme Mix) from Invitrogen (CA, USA). A master mix of 20 μl was prepared in a PCR plate and 5 μl of RNA template was added. Amplifi cation was carried out as given in Table 2: PCR-based identifi cation for hMPV and RSV was carried out with cDNA generated by using BluePrint TM First Strand Synthesis kit (DSS TakaraBio India Pvt. Ltd.) RSV amplifi cation conditions comprised of initial denaturation at 94°C for 3 min, followed by 35 cycling stages at 94°C for 60 s, 50°C for 60 s and 72°C for 60 s, with a fi nal extension at 72°C for 10 min. Similarly, hMPV amplifi cation conditions comprised of initial denaturation at 95°C for 3 min, followed by 35 cycling stages at 95°C for 60 s, 52°C for 45 s and 72°C for 60 s, with a fi nal extension at 72°C for 7 min. After PCR, the amplifi ed product was examined by electrophoresis on an agarose gel containing SYBR safe DNA gel stain (Invitrogen). The results were compared with a DNA molecular weight marker.
Amplifi cation of bacterial genome
Genomic DNA extracted from the clinical samples (5 μl) was added to 20 μl master mix, which contained Fermentas S. aureus amplifi cation conditions comprised of initial denaturation at 94°C for 3 min, followed by 30 cycling stages at 94°C at 30 s, 57.8°C at 30 s, 72°C at 1 min with a fi nal extension at 72°C for 4 min.
S. pneumoniae amplifi cation conditions comprised of initial denaturation at 94°C for 10 min, followed by 40 cycling stages at 94°C at 30 s, 56.5°C at 30 s, 72°C at 1 min with a fi nal extension at 72°C for 7 min.
H. infl uenzae amplifi cation condition comprised of initial denaturation at 94°C for 10 min, followed by 40 cycling stages at 94°C at 30 s 56.2°C at 30 s, 72°C at 1 min with a fi nal extension at 72°C for 7 min.
K. pneumonia amplifi cation conditions comprised of initial denaturation at 95°C for 5 min, followed by 30 cycling stages at 96°C at 60 s, 54.9°C at 30 s, 72°C at 1 min with a fi nal extension at 72°C for 10 min.
The amplifi ed samples were examined by electrophoresis on an agarose gel containing SYBR safe DNA gel stain (Invitrogen). The results were compared with a 100 bp DNA molecular weight marker. In every PCR run, one positive and one negative control for each one of the four investigated bacteria were included.
Statistical analysis
Results presented in the tables were reported as percentage positives. Data was subjected to Graph Pad Prism v5.04 and v6.0, [24] two way analysis of variance (ANOVA) was carried out for symptom with respect to infection with P < 0.001 was considered to be signifi cant.
Results
The samples (N = 200) collected for detection of respiratory infections were broadly categorised into ILI As can be observed from Table 3 , the patients with ILI, viral co-infection was found to be 6.3% positive for infl uenza A and B, whereas 8.1% positivity for pandemic infl uenza A H1N1 and infl uenza type B, as compared to other viral infections, which were predominant. In case of bacterial infections, S. pneumoniae was the major bacterial infection and only a single case of bacterial co-infection with 0.9% positivity was observed. The most signifi cant fi nding was viral-bacterial co-infection with 1.8% positivity for pandemic infl uenza A H1N1 and H. infl uenzae and 0.9% positivity for pandemic infl uenza A H1N1 with infl uenza Type B and S. pneumonia [ Table 3 ].
As can be observed from Table 4 , patients with ARI, pandemic infl uenza A H1N1was predominant with 17.4% positivity as compared with other viral infections. In viral co-infection, seasonal infl uenza A and infl uenza type B accounted for 2.19% positivity. In case of bacterial infections, S. pneumoniae was found to be the major bacterial infection. The most signifi cant fi nding was the viral-bacterial co-infection in which H. infl uenzae was the major co-infecting bacteria with the infl uenza viruses as compared with S. pneumonia [ Table 4 ].
Age-wise distribution
As is illustrated in Graph 1, 30% of the patients who were admitted due to respiratory infection belonged to the paediatric group, which was found to be the most vulnerable to infections as compared with other age groups. The patients of adolescence group (6-20 years) were 11%, whereas the middle aged groups (21-40 years) comprised of 34% [ Figure 1 ].
Month-wise distribution
In Graph 2, to understand the seasonality and trend of circulating infl uenza and bacterial strains, the month-wise percentage distribution was plotted over the total number of samples positive for infl uenza, bacterial infection along with viral-bacterial co-infection for the year July 2011 to July 2012. A minor peak in the infl uenza positivity percentage was observed in the monsoon season (July 2011-September 2011) and bacterial positivity percentage rise during the winter season (July 2011-September 2011) and bacterial percentage positivity rise during the winter seasons (December 2011-January 2012). A major fi nding was for the viral bacterial co-infection, which was observed during the 
Symptomatic and infection positivity
As observed from Figure 3 , a 2 way ANOVA was carried to compare symptoms with infections. Symptoms like temperature (axilla and oral), cough and sore throat were found to be consistent in different types of infl uenza viruses as compared with shortness of breathing and vomiting, which varied. In bacterial infections caused by S. pneumoniae and H. infl uenzae cough was the major symptom. [Figure 3 ].
Discussion
ARIs are responsible for 3.9 million deaths. It is estimated that Bangladesh, India, Indonesia and Nepal together account for 40% of the global ARI mortality. [25] On an average, children aged below 5 years suffer about fi ve episodes of ARI per child per year, thus accounting about 238 million cases. ARI is responsible for about 30-50% of visits to health facilities and for about 20-40% of admissions to hospitals. It is also a leading cause of deafness as sequelae of acute otitis media. [26] We report here that the percentage positivity for pandemic infl uenza A H1N1 is about 19.2% in patients with ILI as compared with 17.4% in patients with ARIs. The most signifi cant fi nding in the study was infl uenza type B seen to be co-circulating strain with 11.9% positivity in contrast to seasonal infl uenza A where only 8% and 7.5% positivity was observed in ILI and ARI, respectively.
As reported by a surveillance study carried out in Delhi, [27] pandemic infl uenza A H1N1 and infl uenza type B accounted for almost equal distribution in 2007, with predominance of infl uenza type B in 2008. Pandemic infl uenza A accounted for 50% infections both in 2009 and 2010, whereas infl uenza A (H3N2) accounted for 35% infections in 2009 and infl uenza type B for 44% infections in 2010.
Previous reports of prevalence studies carried out at Haffkine Institute [28] demonstrated the screening of 100 children for infl uenza type A and infl uenza type B and it was noted that 11 were positive for infl uenza type A and only 5 were positive for infl uenza type B. However, they did not carry out any screening for other respiratory viruses like RSV and hMPV neither for any viral nor bacterial co-infections.
RSV was the most common identifi ed viral pathogen in children aged below 5 years in Delhi from April 2005 to Mach 2007 where 301 nasopharyngeal aspirates were collected showing the symptoms of ALRIs and the incidence of RSV positives was 20.26%. [19] With such a high incidence of RSV infection prevailing in Delhi, we carried out the screening of the samples for RSV in addition to infl uenza viruses. The positivity for RSV accounted for 0.9% and 1.09% in ILI and ARI, respectively.
A preliminary study carried out in Pune [25] during the 2-month period, which included 9 children and 18 adults, hMPV RNA was detected in 19.2% of the children, while it was undetected in adults. Hence it may be speculated that hMPV may well exist in the Indian population. These facts suggest the importance of screening of hMPV, therefore, we screened all samples for hMPV and none of the patients were found to be positive in the study group we selected.
Bacterial pneumonia complicating viral infl uenza was reported during the pandemic of 1918 and multiple subsequent epidemic and inter-epidemic periods. [29] The most common pathogens were S. pneumoniae, S. aureus, H. infl uenzae and occasionally other Gram-negative bacilli. [30] During the 2006-2007 infl uenza season, cases of severe community-acquired pneumonia due to methicillin-resistant Staphylococcus aureus (MRSA) were reported with 33% mortality. [31] These show an increase in the morbidity and mortality when infl uenza was associated with another underlying respiratory infection, usually of bacterial origin. The mechanisms by which bacteria act synergistically with infl uenza virus includes increased binding and invasion of bacteria along with viral replication and modifi cation of the host infl ammatory response. The interactions between infl uenza virus and bacteria have most thoroughly been established with S. pneumoniae, where the viral neuraminidase of infl uenza virus cleaves the sialic acid to release new viral particles from host cells, which results the damage of the epithelial layer of the airways and expose the binding sites necessary for adherence of the pneumococcus. [32] In one of the studies, [33] the author stated co-infection with infl uenza and bacterial pathogens occurred more frequently in pandemic as compared with seasonal infl uenza periods. Of these, S. pneumoniae was the most common cause of bacterial co-infection with infl uenza and accounted for 40.8% and 16.6% of bacterial co-infections during pandemic and seasonal periods, respectively. These results suggest that bacterial pathogens will play a key role in many countries, as the infl uenza pandemic moves forward.
The increasing evidence of bacterial infection along with the infl uenza viruses impelled us to screen all the samples for bacterial infections. We observed that S. pneumoniae and H. infl uenzae were the major bacterial infections encountered in patients with respiratory infections. The incidence for viral-bacterial co-infection could also be clearly observed in both ILI and ARI with positivity accounting for 0.9% and 1.09% respectively.
In the present study, month-wise distribution was also observed for the viral and bacterial positivity and it displayed that infl uenza positivity peaked during the monsoon seasons (July 2011 and June 2012-July 2012). The bacterial infections were predominant during winter season (December 2011 and January 2012). The co-infection between the bacterial and viral pathogens was observed during the monsoons of June 2012 and July 2012.
We report here that seasonal peaks of infl uenza activity in India are consistent with data from surrounding countries in the region, where peaks of infl uenza activities coincide with rainy seasons. [34, 35] In some tropical regions; there is high background infl uenza activity throughout the year with distinct peaks appearing during monsoon or cooler months. [36] While the exact mechanisms leading to variation in infl uenza seasonality are not clear, attempts to correlate fl uctuation in meteorological variables have shown relationship with infl uenza positivity during the rainy season in the tropics. [37] Multi-site infl uenza surveillance from different geographic regions in India has also revealed a positive correlation between the rainy season and rates of infl uenza virus isolation.
In the clinical presentation of symptoms versus infection where a 2 way ANOVA was carried out; signifi cant fi ndings (P < 0.01) were observed for cough and sore throat in pandemic infl uenza A in comparison to nasal catarrh, shortness of breathing and vomiting for bacterial infections.
Conclusion
Taken together, our data provides evidence about signifi cance of bacterial infection, which needs to be carried out along with viral infections in patients presenting with respiratory symptoms. This study highlights the existence of viral-bacterial co-infection, which also holds an importance in cases of antimicrobial resistance so that appropriate drugs could be prescribed to encounter such infections. Together with other studies, our data imply that the diagnosis of viruses and bacteria in ILI and ARI patients should be performed on daily basis. This would help in patient management, treatment and prevention of viral and bacterial infection.
We are aware that the available diagnostic tools for point of care diagnosis are not optimal and we are also aware that virus therapy has to be further improved. We hope that the fi ndings of our study can alert clinicians regarding the risk of viral and bacterial infection in patients and stimulate the development of diagnostic tools as well as therapeutic strategies. The need of the hour is to undertake continued surveillance globally, which will help to better defi ne the circulation of infl uenza viruses along with the bacterial infections, as well as to determine optimal periods to implement vaccination programmes among the priority population.
